동맥류성 지주막하 출혈 시장 규모, 점유율, 성장 분석 : 치료법별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Aneurysmal Subarachnoid Hemorrhage Market size was valued at USD 170.0 Million in 2024 and is poised to grow from USD 173.4 Million in 2025 to USD 203.17 Million by 2033, growing at a CAGR of 2.0% during the forecast period (2026-2033).

The global aneurysmal subarachnoid hemorrhage (aSAH) market encompasses diagnostic tools, endovascular devices, neurosurgical instruments, and patient care services aimed at addressing intracranial aneurysm ruptures. Due to aSAH's high mortality rate and significant contribution to total strokes, there is a pressing need for advanced imaging and minimally invasive treatment options. The market has transitioned from surgical clipping to endovascular solutions, primarily driven by the adoption of coil embolization. This shift emphasizes rapid intervention, thus fostering investments in cutting-edge imaging technologies like CT and MRI, which not only enhance diagnosis but also expand patient access to treatment. The integration of AI-driven diagnostic imaging further accelerates this trend by improving detection accuracy and facilitating quicker clinical decision-making, ultimately broadening market opportunities, particularly in emerging regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aneurysmal Subarachnoid Hemorrhage market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aneurysmal Subarachnoid Hemorrhage Market Segments Analysis

Global aneurysmal subarachnoid hemorrhage market is segmented by intervention type, end-user, distribution channel and region. Based on intervention type, the market is segmented into Surgical Clipping, Endovascular Coiling, Flow Diverters & Stents and Pharmacological Management. Based on end-user, the market is segmented into Hospitals & Neurological Centers and Ambulatory Surgical Centers. Based on distribution channel, the market is segmented into Direct and Indirect. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aneurysmal Subarachnoid Hemorrhage Market

One of the key market drivers for the global aneurysmal subarachnoid hemorrhage market is the increasing prevalence of cerebral aneurysms and associated risk factors, such as hypertension, smoking, and genetic predispositions. As awareness surrounding neurological disorders grows, there is a rising demand for advanced diagnostic and therapeutic options. This situation is further exacerbated by the aging population, which typically has a higher incidence of cerebrovascular conditions. Innovations in minimally invasive surgical techniques and the development of specialized medical devices are also propelling market growth, as healthcare providers seek effective interventions to improve patient outcomes and reduce the burden of this critical health issue.

Restraints in the Global Aneurysmal Subarachnoid Hemorrhage Market

One significant market restraint for the global aneurysmal subarachnoid hemorrhage market is the high cost associated with advanced diagnostic imaging technologies and treatment options. These expenses can limit accessibility for patients and healthcare providers, particularly in low-resource settings. Additionally, the complexity of the condition often necessitates a multidisciplinary approach to care, which can further strain healthcare budgets. The lack of public awareness and understanding of aneurysmal subarachnoid hemorrhage also contributes to late diagnoses, hindering timely treatment and impacting overall market growth. Consequently, these factors may stifle investment and innovation within this critical area of healthcare.

Market Trends of the Global Aneurysmal Subarachnoid Hemorrhage Market

The Global Aneurysmal Subarachnoid Hemorrhage market is experiencing a significant shift towards the adoption of minimally invasive techniques. Healthcare providers are increasingly embracing advanced surgical options such as endovascular coils and flow diverters, which minimize trauma, enhance recovery times, and reduce hospital stays for patients. This trend is prompting hospitals to invest in specialized catheter laboratories and robust training programs for medical professionals. In tandem, insurance companies are adapting reimbursement policies to support less invasive procedures, creating a more favorable environment for innovation. As a result, there is heightened competition among manufacturers striving to capture market share, leading to accelerated advancements in device technology and treatment methodologies.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Aneurysmal Subarachnoid Hemorrhage Market Size by Intervention Type & CAGR (2026-2033)

• Market Overview
• Surgical Clipping
• Endovascular Coiling
  • Bare Platinum Coils
  • Coated & Hydrogel Coils
• Flow Diverters & Stents
• Pharmacological Management

Global Aneurysmal Subarachnoid Hemorrhage Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals & Neurological Centers
• Ambulatory Surgical Centers

Global Aneurysmal Subarachnoid Hemorrhage Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct
• Indirect

Global Aneurysmal Subarachnoid Hemorrhage Market Size & CAGR (2026-2033)

• North America (Intervention Type, End-User, Distribution Channel)
  • US
  • Canada
• Europe (Intervention Type, End-User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Intervention Type, End-User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Intervention Type, End-User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Intervention Type, End-User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phenox
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edge Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations